drugset / Trial / NCT07222098

A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)

NCT07222098

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

Researchers want to learn about calderasib when given with rosuvastatin and metformin in healthy people. The goal of this study is to compare the amount of rosuvastatin and metformin in a person's body over time when given with and without calderasib

Timeline

Start
2025-11-19
Primary completion
2025-12-14
Completion
2025-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Calderasib Unknown Oral
Subject Metformin Small molecule Oral
Subject Rosuvastatin Small molecule Oral

Indications

No indication recorded.